Sysmex

At Sysmex, we are dedicated to enhancing patient care in cancer management. Our innovative diagnostic solutions reflect our commitment to addressing individual patient needs. MammaTyper® is a molecular diagnostic test that precisely quantifies the expression of HER2, ER, PR, and Ki-67 mRNA, key biomarkers in breast cancer subtyping. This test aids in the assessment of St. Gallen Breast Cancer subtypes, crucial for treatment decisions. By improving diagnostic efficiency and reducing side effects, we strive to make a positive impact on patient wellbeing and healthcare professionals' work lives.